Anders Larnholt has 20 years of pharma and healthcare experience from various executive positions, M&A, strategic advisory and board positions at Meda, Trimb Healthcare and other companies. In his latest role, he co-founded Trimb Healthcare that was sold to EQT and Karo pharma in 2019. Anders Larnholt has in previous positions completed 100+ pharma and healthcare deals with a total acquisition value of more than EUR 4 billion. Deals include European and global product acquisitions and licensing deals from international pharma companies such as Roche, Novartis, GSK, J&J as well as many mid-cap pharma companies. Numerous companies and other assets have also been acquired from private equity firms and private individuals. These initiatives transformed previous companies from small Swedish firms to large pharma corporations with thousands of employees and own operations in more than 50 countries.
About Impilo Impilo is a Nordic-based investment company focused on investments in healthcare and the health-related sector. Our starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which they operate in order to remain successful in the long term. To find out more, visit www.impilo.se
Magnus Edlund is a Partner at Impilo and a Board Member of Mallax Pharmaceuticals AB.E-mail firstname.lastname@example.org